Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Hisamitsu To Go Private For Long-Term Growth Through $2.6bn MBO
Jan 09 2026
•
By
Lisa Takagi
Japanese firm's broad strategy will remain unchanged after the MBO led by CEO Kazuhide Nakatomi
(Shutterstock)
More from Japan
More from Focus On Asia